Oxford Biomedica (OXB.L) Stock Price
£313.5 0.2%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Oxford Biomedica, AI stock picks, stock alerts and much more.
OXB.L AI Stock Analysis
AI stock analysis for OXB.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Oxford Biomedica (OXB.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Oxford Biomedica (OXB.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Oxford Biomedica (OXB.L), currently trading at £313.5, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About OXB.L
-
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally.
-
Symbol
OXB.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
332.6M
Similar Stocks
 |
Codexis 0I0X.L |
$2.35 4.5% |
4 |
 |
Oxford Nanopore Technologies plc ONT.L |
£119.2 0.4% |
5 |
 |
Sareum Holdings SAR.L |
£15.49 1.7% |
6 |
 |
Viridian Therapeutics 0K1R.L |
$15.28 3.5% |
5 |
 |
Avacta Group Plc AVCT.L |
£30.5 3.4% |
2 |
News
OXB.L Alternative Data
Web Traffic
Oxford Biomedica receives an estimated 10729 monthly visitors to oxb.com.
-
Web Traffic
10729
-
Change from Previous Month
14%
-
3 Month Change
37.8%
-
YoY Change
37.8%
Youtube Subscribers
Oxford Biomedica has 145 subscribers on its main Youtube channel, up by 2.1% over the last month.
-
Youtube Subscribers
145
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
4.3%
Job Postings
Oxford Biomedica currenly has an estimated 28 open job postings, up by 16.7% over the last month.
-
Job Postings
28
-
Daily Change
7.7%
-
1 Month Change
16.7%
-
3 Month Change
21.7%
Reddit Mentions
Oxford Biomedica has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
46,822 are following Oxford Biomedica on LinkedIn, up by 2% over the last month.
-
LinkedIn Followers
46822
-
Daily Change
2%
-
1 Month Change
2%
-
3 Month Change
6.7%
-
YoY Change
6.7%
LinkedIn Employees
According to LinkedIn, Oxford Biomedica has 831 employees, up by 1.1% over the last month.
-
LinkedIn Employees
831
-
Daily Change
1.1%
-
1 Month Change
1.1%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Business Outlook
According to employee reviews, the business outlook among employees at Oxford Biomedica is 44 out of 100 (neutral).
-
Business Outlook
44
-
Change from Previous Month
10%
-
3 Month Change
10%
-
YoY Change
10%
News Mentions
Oxford Biomedica was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
OXB.L Financials
OXB.L Key Metrics
-
Total Revenue
£78M
-
Net Income
-£10.7M
-
Earnings per Share
-£0.1
-
Free cash flow
-£14.5M
-
EBITDA
£5M
-
EBITDA Ratio
0.0643664
-
Total Assets
£231.6M
OXB.L 2-year Revenue & Income
OXB.L 2-year Free Cash Flow
OXB.L Technicals
OXB.L SMA
OXB.L RSI
FAQ
What's the current price of Oxford Biomedica (OXB.L) Stock?
The price of an Oxford Biomedica (OXB.L) share is £313.5.
What's the market cap of Oxford Biomedica?
The current market cap of Oxford Biomedica is 332.6M.
Should I buy or sell OXB.L?
Oxford Biomedica shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Oxford Biomedica is better viewed as a hold or accumulate position while waiting for further developments.
Is Oxford Biomedica a good investment?
The current analysis of Oxford Biomedica's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Oxford Biomedica's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Oxford Biomedica (OXB.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Oxford Biomedica stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Oxford Biomedica (OXB.L) that investors often compare it to?
Oxford Biomedica (OXB.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Oxford Biomedica's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Oxford Biomedica's stock price to be around £305.2 in 2026. Starting from the current price of £313.5, this represents a 2.6% change in price, indicating a neutral outlook for the stock.
How to buy Oxford Biomedica (OXB.L) Stock?
Oxford Biomedica stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Oxford Biomedica shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.